2-(2,6-dimethylphenyl)-3-[1-(2,2-dimethylpropyl)imidazol-2-yl]-4H-pyridin-4-ide;2-(2,6-dimethylphenyl)-3-(1-methylpyrazol-3-yl)-4H-pyridin-4-ide;6-(2,6-dimethylphenyl)-5-(1-methylpyrazol-3-yl)-4H-pyrimidin-4-ide;2-(2,6-dimethylphenyl)-3-pyrazol-1-yl-4H-pyridin-4-ide;tetrakis(iridium)

C70H69Ir4N13-4 — CID 159227829

IUPAC2-(2,6-dimethylphenyl)-3-[1-(2,2-dimethylpropyl)imidazol-2-yl]-4H-pyridin-4-ide;2-(2,6-dimethylphenyl)-3-(1-methylpyrazol-3-yl)-4H-pyridin-4-ide;6-(2,6-dimethylphenyl)-5-(1-methylpyrazol-3-yl)-4H-pyrimidin-4-ide;2-(2,6-dimethylphenyl)-3-pyrazol-1-yl-4H-pyridin-4-ide;tetrakis(iridium)
SMILESCc1cccc(C)c1-c1ncc[c-]c1-c1ccn(C)n1.Cc1cccc(C)c1-c1ncc[c-]c1-c1nccn1CC(C)(C)C.Cc1cccc(C)c1-c1ncc[c-]c1-n1cccn1.Cc1cccc(C)c1-c1ncn[c-]c1-c1ccn(C)n1.[Ir].[Ir].[Ir].[Ir]
InChIInChI=1S/C21H24N3.C17H16N3.C16H15N4.C16H14N3.4Ir/c1-15-8-6-9-16(2)18(15)19-17(10-7-11-22-19)20-23-12-13-24(20)14-21(3,4)5;1-12-6-4-7-13(2)16(12)17-14(8-5-10-18-17)15-9-11-20(3)19-15;1-11-5-4-6-12(2)15(11)16-13(9-17-10-18-16)14-7-8-20(3)19-14;1-12-6-3-7-13(2)15(12)16-14(8-4-9-17-16)19-11-5-10-18-19;;;;/h6-9,11-13H,14H2,1-5H3;4-7,9-11H,1-3H3;4-8,10H,1-3H3;3-7,9-11H,1-2H3;;;;/q4*-1;;;;
InChIKeyXCGMLKFZSIHLJH-UHFFFAOYSA-N
MW1861.28 g/mol
LogP14.94
Rot. Bonds9

About 2-(2,6-dimethylphenyl)-3-[1-(2,2-dimethylpropyl)imidazol-2-yl]-4H-pyridin-4-ide;2-(2,6-dimethylphenyl)-3-(1-methylpyrazol-3-yl)-4H-pyridin-4-ide;6-(2,6-dimethylphenyl)-5-(1-methylpyrazol-3-yl)-4H-pyrimidin-4-ide;2-(2,6-dimethylphenyl)-3-pyrazol-1-yl-4H-pyridin-4-ide;tetrakis(iridium)

2-(2,6-dimethylphenyl)-3-[1-(2,2-dimethylpropyl)imidazol-2-yl]-4H-pyridin-4-ide;2-(2,6-dimethylphenyl)-3-(1-methylpyrazol-3-yl)-4H-pyridin-4-ide;6-(2,6-dimethylphenyl)-5-(1-methylpyrazol-3-yl)-4H-pyrimidin-4-ide;2-(2,6-dimethylphenyl)-3-pyrazol-1-yl-4H-pyridin-4-ide;tetrakis(iridium) (PubChem CID 159227829) has the molecular formula C70H69Ir4N13-4 and a molecular weight of 1861.28 g/mol. Its IUPAC name is 2-(2,6-dimethylphenyl)-3-[1-(2,2-dimethylpropyl)imidazol-2-yl]-4H-pyridin-4-ide;2-(2,6-dimethylphenyl)-3-(1-methylpyrazol-3-yl)-4H-pyridin-4-ide;6-(2,6-dimethylphenyl)-5-(1-methylpyrazol-3-yl)-4H-pyrimidin-4-ide;2-(2,6-dimethylphenyl)-3-pyrazol-1-yl-4H-pyridin-4-ide;tetrakis(iridium).

Molecular Properties

Compound Name2-(2,6-dimethylphenyl)-3-[1-(2,2-dimethylpropyl)imidazol-2-yl]-4H-pyridin-4-ide;2-(2,6-dimethylphenyl)-3-(1-methylpyrazol-3-yl)-4H-pyridin-4-ide;6-(2,6-dimethylphenyl)-5-(1-methylpyrazol-3-yl)-4H-pyrimidin-4-ide;2-(2,6-dimethylphenyl)-3-pyrazol-1-yl-4H-pyridin-4-ide;tetrakis(iridium)
PubChem CID159227829
Molecular FormulaC70H69Ir4N13-4
Molecular Weight1861.28 g/mol
Exact Mass1863.43
IUPAC Name2-(2,6-dimethylphenyl)-3-[1-(2,2-dimethylpropyl)imidazol-2-yl]-4H-pyridin-4-ide;2-(2,6-dimethylphenyl)-3-(1-methylpyrazol-3-yl)-4H-pyridin-4-ide;6-(2,6-dimethylphenyl)-5-(1-methylpyrazol-3-yl)-4H-pyrimidin-4-ide;2-(2,6-dimethylphenyl)-3-pyrazol-1-yl-4H-pyridin-4-ide;tetrakis(iridium)
SMILESCc1cccc(C)c1-c1ncc[c-]c1-c1ccn(C)n1.Cc1cccc(C)c1-c1ncc[c-]c1-c1nccn1CC(C)(C)C.Cc1cccc(C)c1-c1ncc[c-]c1-n1cccn1.Cc1cccc(C)c1-c1ncn[c-]c1-c1ccn(C)n1.[Ir].[Ir].[Ir].[Ir]
InChIInChI=1S/C21H24N3.C17H16N3.C16H15N4.C16H14N3.4Ir/c1-15-8-6-9-16(2)18(15)19-17(10-7-11-22-19)20-23-12-13-24(20)14-21(3,4)5;1-12-6-4-7-13(2)16(12)17-14(8-5-10-18-17)15-9-11-20(3)19-15;1-11-5-4-6-12(2)15(11)16-13(9-17-10-18-16)14-7-8-20(3)19-14;1-12-6-3-7-13(2)15(12)16-14(8-4-9-17-16)19-11-5-10-18-19;;;;/h6-9,11-13H,14H2,1-5H3;4-7,9-11H,1-3H3;4-8,10H,1-3H3;3-7,9-11H,1-2H3;;;;/q4*-1;;;;
InChIKeyXCGMLKFZSIHLJH-UHFFFAOYSA-N
XLogP14.94
TPSA135.73 Ų
H-Bond Donors
H-Bond Acceptors13
Rotatable Bonds9
Heavy Atoms87
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001861.28
LogP ≤ 514.94
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 2-(2,6-dimethylphenyl)-3-[1-(2,2-dimethylpropyl)imidazol-2-yl]-4H-pyridin-4-ide;2-(2,6-dimethylphenyl)-3-(1-methylpyrazol-3-yl)-4H-pyridin-4-ide;6-(2,6-dimethylphenyl)-5-(1-methylpyrazol-3-yl)-4H-pyrimidin-4-ide;2-(2,6-dimethylphenyl)-3-pyrazol-1-yl-4H-pyridin-4-ide;tetrakis(iridium) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-(2,6-dimethylphenyl)-3-[1-(2,2-dimethylpropyl)imidazol-2-yl]-4H-pyridin-4-ide;2-(2,6-dimethylphenyl)-3-(1-methylpyrazol-3-yl)-4H-pyridin-4-ide;6-(2,6-dimethylphenyl)-5-(1-methylpyrazol-3-yl)-4H-pyrimidin-4-ide;2-(2,6-dimethylphenyl)-3-pyrazol-1-yl-4H-pyridin-4-ide;tetrakis(iridium)?
The IUPAC name of 2-(2,6-dimethylphenyl)-3-[1-(2,2-dimethylpropyl)imidazol-2-yl]-4H-pyridin-4-ide;2-(2,6-dimethylphenyl)-3-(1-methylpyrazol-3-yl)-4H-pyridin-4-ide;6-(2,6-dimethylphenyl)-5-(1-methylpyrazol-3-yl)-4H-pyrimidin-4-ide;2-(2,6-dimethylphenyl)-3-pyrazol-1-yl-4H-pyridin-4-ide;tetrakis(iridium) (CID 159227829) is 2-(2,6-dimethylphenyl)-3-[1-(2,2-dimethylpropyl)imidazol-2-yl]-4H-pyridin-4-ide;2-(2,6-dimethylphenyl)-3-(1-methylpyrazol-3-yl)-4H-pyridin-4-ide;6-(2,6-dimethylphenyl)-5-(1-methylpyrazol-3-yl)-4H-pyrimidin-4-ide;2-(2,6-dimethylphenyl)-3-pyrazol-1-yl-4H-pyridin-4-ide;tetrakis(iridium).
What is the SMILES notation for 2-(2,6-dimethylphenyl)-3-[1-(2,2-dimethylpropyl)imidazol-2-yl]-4H-pyridin-4-ide;2-(2,6-dimethylphenyl)-3-(1-methylpyrazol-3-yl)-4H-pyridin-4-ide;6-(2,6-dimethylphenyl)-5-(1-methylpyrazol-3-yl)-4H-pyrimidin-4-ide;2-(2,6-dimethylphenyl)-3-pyrazol-1-yl-4H-pyridin-4-ide;tetrakis(iridium)?
The canonical SMILES for 2-(2,6-dimethylphenyl)-3-[1-(2,2-dimethylpropyl)imidazol-2-yl]-4H-pyridin-4-ide;2-(2,6-dimethylphenyl)-3-(1-methylpyrazol-3-yl)-4H-pyridin-4-ide;6-(2,6-dimethylphenyl)-5-(1-methylpyrazol-3-yl)-4H-pyrimidin-4-ide;2-(2,6-dimethylphenyl)-3-pyrazol-1-yl-4H-pyridin-4-ide;tetrakis(iridium) is Cc1cccc(C)c1-c1ncc[c-]c1-c1ccn(C)n1.Cc1cccc(C)c1-c1ncc[c-]c1-c1nccn1CC(C)(C)C.Cc1cccc(C)c1-c1ncc[c-]c1-n1cccn1.Cc1cccc(C)c1-c1ncn[c-]c1-c1ccn(C)n1.[Ir].[Ir].[Ir].[Ir].
What is the InChIKey of 2-(2,6-dimethylphenyl)-3-[1-(2,2-dimethylpropyl)imidazol-2-yl]-4H-pyridin-4-ide;2-(2,6-dimethylphenyl)-3-(1-methylpyrazol-3-yl)-4H-pyridin-4-ide;6-(2,6-dimethylphenyl)-5-(1-methylpyrazol-3-yl)-4H-pyrimidin-4-ide;2-(2,6-dimethylphenyl)-3-pyrazol-1-yl-4H-pyridin-4-ide;tetrakis(iridium)?
The InChIKey is XCGMLKFZSIHLJH-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H24N3.C17H16N3.C16H15N4.C16H14N3.4Ir/c1-15-8-6-9-16(2)18(15)19-17(10-7-11-22-19)20-23-12-13-24(20)14-21(3,4)5;1-12-6-4-7-13(2)16(12)17-14(8-5-10-18-17)15-9-11-20(3)19-15;1-11-5-4-6-12(2)15(11)16-13(9-17-10-18-16)14-7-8-20(3)19-14;1-12-6-3-7-13(2)15(12)16-14(8-4-9-17-16)19-11-5-10-18-19;;;;/h6-9,11-13H,14H2,1-5H3;4-7,9-11H,1-3H3;4-8,10H,1-3H3;3-7,9-11H,1-2H3;;;;/q4*-1;;;;.
What are the key properties of 2-(2,6-dimethylphenyl)-3-[1-(2,2-dimethylpropyl)imidazol-2-yl]-4H-pyridin-4-ide;2-(2,6-dimethylphenyl)-3-(1-methylpyrazol-3-yl)-4H-pyridin-4-ide;6-(2,6-dimethylphenyl)-5-(1-methylpyrazol-3-yl)-4H-pyrimidin-4-ide;2-(2,6-dimethylphenyl)-3-pyrazol-1-yl-4H-pyridin-4-ide;tetrakis(iridium)?
2-(2,6-dimethylphenyl)-3-[1-(2,2-dimethylpropyl)imidazol-2-yl]-4H-pyridin-4-ide;2-(2,6-dimethylphenyl)-3-(1-methylpyrazol-3-yl)-4H-pyridin-4-ide;6-(2,6-dimethylphenyl)-5-(1-methylpyrazol-3-yl)-4H-pyrimidin-4-ide;2-(2,6-dimethylphenyl)-3-pyrazol-1-yl-4H-pyridin-4-ide;tetrakis(iridium) has a molecular weight of 1861.28 g/mol, XLogP of 14.94, 9 rotatable bonds, 0 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(2,6-dimethylphenyl)-3-[1-(2,2-dimethylpropyl)imidazol-2-yl]-4H-pyridin-4-ide;2-(2,6-dimethylphenyl)-3-(1-methylpyrazol-3-yl)-4H-pyridin-4-ide;6-(2,6-dimethylphenyl)-5-(1-methylpyrazol-3-yl)-4H-pyrimidin-4-ide;2-(2,6-dimethylphenyl)-3-pyrazol-1-yl-4H-pyridin-4-ide;tetrakis(iridium) is sourced from PubChem (CID 159227829), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).